Cart
sales@molnova.com
CC618
CAS No. 1680204-90-3
CC618( —— )
Catalog No. M28891 CAS No. 1680204-90-3
CC618 is a selective PPARβ/δ antagonist with an IC50 of 10.0 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 314 | In Stock |
|
| 5MG | 249 | In Stock |
|
| 10MG | 369 | In Stock |
|
| 25MG | 562 | In Stock |
|
| 50MG | 770 | In Stock |
|
| 100MG | 1032 | In Stock |
|
| 200MG | 1376 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCC618
-
NoteResearch use only, not for human use.
-
Brief DescriptionCC618 is a selective PPARβ/δ antagonist with an IC50 of 10.0 μM.
-
DescriptionCC618 is a selective PPARβ/δ antagonist with an IC50 of 10.0 μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorHedgehog
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1680204-90-3
-
Formula Weight523.47
-
Molecular FormulaC20H15F6N3O3S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1c(C(NCCS(c2ncc(C(F)(F)F)cc2)(=O)=O)=O)sc(-c2ccc(C(F)(F)F)cc2)n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Williams JA, et al. Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions.Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4616-21. Epub 2003 Apr 4.
molnova catalog
related products
-
Sakuranetin
Sakuranetin, a flavanone phytoalexin from ultraviolet-irradiated rice leaves, it has antifungal, antimutagenic, anti-inflammatory and antioxidant effects.
-
Fucosterol
Fucosterol is isolated from E. stolonifera with anti-diabetic anti-adipogenic and anti-cancer activities. It regulates adipogenesis via modulation of PPARα and C/EBPα expression.
-
(R)-(+)-Bay-K-8644
(R)-(+)-Bay-K-8644 is a Ca2+ channel and dihydropyridine agonist that inhibits Ba2+ currents (IBa), induces central respiratory depression in cats, and inhibits platelet activation through competitive antagonism of thromboxane A2-prostaglandin H2 receptors.
